Article Information
History
- June 4, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Diana Rofail, PhD¶,1,
- Nadine McGale, PhD2,
- Anna J. Podolanczuk, MD3,
- Alissa Rams, BA2,
- Krystian Przydzial, BSc2,
- Sumathi Sivapalasingam, MD1,
- Vera Mastey, MS1 and
- Patrick Marquis, MD2
- 1Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA
- 2Modus Outcomes, Letchworth Garden City, UK
- 3Weill Cornell Medical College, New York, NY, USA
- ↵¶Corresponding author: Diana Rofail, 777 Old Saw Mill River Rd, Tarrytown, NY 10591-6707. Email: diana.rofail{at}regeneron.com. Phone: +1 (914) 479 7269